Long-Term Efficacy of Dupilumab in Patients with Moderate-To-Severe Type 2 Asthma Stratified by Baseline Characteristics During the 96-Week TRAVERSE Study

Michael Wechsler,Linda Rogers,Giorgio Canonica,Arnaud Bourdin,Arman Altincatal,Megan Hardin,Xavier Soler,Paul Rowe,Yamo Deniz,Harry Sacks,Juby Jacob-Nara

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY（2024）

Cited 0|Views24
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined